Matching slides 24,547
Current window 15,691-15,720
Pages 819
Rows per page 30
Slide function: Present Solutionclear collectionreset all

Slide function

15,691-15,720 of 24,547

filter-aware
06
The slide uses a dot-matrix representation to indicate therapeutic focus areas for specific drug candidates.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
10
The slide uses a biological pathway diagram to illustrate the mechanism of action and a callout box for the therapeutic thesis.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
51
Includes a DepMap CRISPR sensitivity plot and a biological pathway diagram illustrating the feedback loop.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
52
Includes a biological pathway diagram and Western blot data comparing a degrader (KT-253) to an inhibitor (DS-3032).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
55
The slide presents five bar charts showing protein levels across different dosing regimens and time points.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
58
The slide uses a split-layout to contrast mechanism benefits (left) with strategic market opportunity (right).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
12
The slide uses a horizontal flow diagram to connect business segments to their respective financial or operational outcomes.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · NeedLoop · Quick Win Big Bet1 hit
29
The slide uses a process flow diagram to map business models to specific supply chain activities.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
31
The slide uses a callout box to emphasize the value proposition of the partnership.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
32
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
54
The slide uses a 2x2 grid layout to present strategic pillars for ESG improvement.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
56
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
12
The slide outlines strategic goals and specific operational implementations for supply chain transparency.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations Beat · KPIs and TargetsLoop · Cost Of Inaction1 hit
04
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Problem1 hit
05
Includes product imagery of the kit and collection tubes.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · Product1 hit
08
The slide outlines the technical workflow from sample collection to patient report generation.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · Product1 hit
13
The slide outlines the technical workflow from sample collection (FIT tube and DNA stabilization tube) through analysis (FIT, DNA extraction, Genetic analysis) to reporting.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
The slide outlines a dual-path diagnostic process involving sample collection, extraction, analysis, and proprietary software reporting.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
19
Mainz Biomed NV | Investor Presentation Deck | 25 slidesMainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
18
The slide uses a hub-and-spoke diagram to center the Maris brand identity while surrounding it with key value propositions.Maris-Tech | Investor Presentation Deck | 28 slides · Maris-Tech
Deck Investor relations Beat · ProductLoop · Why Now1 hit
19
Maris-Tech | Investor Presentation Deck | 28 slidesMaris-Tech | Investor Presentation Deck | 28 slides · Maris-Tech
Deck Investor relations Beat · ProductLoop · Why Now1 hit
20
The slide uses a callout-based diagram to explain the features of a hardware device in the context of space exploration.Maris-Tech | Investor Presentation Deck | 28 slides · Maris-Tech
Deck Investor relations Beat · ProductLoop · Why Now1 hit
21
Maris-Tech | Investor Presentation Deck | 28 slidesMaris-Tech | Investor Presentation Deck | 28 slides · Maris-Tech
Deck Investor relations Loop · Why Now1 hit
23
Maris-Tech | Investor Presentation Deck | 28 slidesMaris-Tech | Investor Presentation Deck | 28 slides · Maris-Tech
Deck Investor relations Beat · FinancialsLoop · Why Now1 hit
24
MindMed | Investor Day Presentation Deck | 61 slidesMindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Beat · Agitate (Make it worse)1 hit
07
The slide uses a matrix structure to categorize drug development strategy by generation (Classic, 2nd Gen/Optimized, 3rd Gen/NCEs).MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
Uses a brain diagram to map specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Uses a brain scan visualization to illustrate the impact of a serotonin agonist.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · Market Size1 hit
21
The chart demonstrates the therapeutic index advantage of the R-enantiomer.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
24
The slide uses a line chart metaphor to show patient stability over time, highlighting the 'gap' filled by MM-110.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit